Panton-Valentine leukocidin positive MRSA in 2003: the Dutch situation

W J B Wannet; M E Heck; G N Pluister; E Spalburg; M G Van Santen; X W Huijsdans; E Tiemersma; A J de Neeling

doi:10.2807/esm.09.11.00484-en

Surveillance report Open Access

Like 0

This item has no PDF Download

Panton-Valentine leukocidin positive MRSA in 2003: the Dutch situation
W J B Wannet¹ , M E Heck¹ , G N Pluister¹ , E Spalburg¹ , M G Van Santen¹ , X W Huijsdans¹ , E Tiemersma¹ , A J de Neeling¹
View Affiliations Hide Affiliations

Affiliations: ¹ National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands

Correspondence:
View Citation Hide Citation

Citation style for this article: Wannet W J B, Heck M E, Pluister G N, Spalburg E, Van Santen M G, Huijsdans X W, Tiemersma E, de Neeling A J. Panton-Valentine leukocidin positive MRSA in 2003: the Dutch situation. Euro Surveill. 2004;9(11):pii=484. https://doi.org/10.2807/esm.09.11.00484-en

Abstract

Analysis of methicillin-resistant Staphylococcus aureus (MRSA) isolates in the Netherlands in 2003 revealed that 8% of the hospital isolates carried the loci for Panton-Valentine leukocidin (PVL). Molecular subtyping showed that most Dutch PVL-MRSA genotypes corresponded to well-documented global epidemic types. The most common PVL-MRSA genotypes were sequence type ST8, ST22, ST30, ST59 and ST80. MRSA with ST8 increased in the Netherlands from 1% in 2002 to 17% in 2003. It is emphasised that PVL-MRSA might not only emerge in the community, but also in the hospital environment.